Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Variants resulting in a decrease or complete loss of enzymatic activity but causing an increase in pathway activity #651

Open
dsonkin opened this issue Oct 18, 2024 · 0 comments

Comments

@dsonkin
Copy link

dsonkin commented Oct 18, 2024

Hello,

Some variants may result in a decrease or complete loss of enzymatic activity but cause an increase in pathway activity due to dimerization and/or feedback signaling. BRAF class 3 variants, which result in a decrease or complete loss of BRAF kinase activity and an increase in MAPK/ERK pathway activity due to increased signaling through CRAF (RAF1), are examples of such variants. Was the creation of the term to describe such variants discussed at some point in the past?

Thank you,
Dmitriy

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
Projects
None yet
Development

No branches or pull requests

1 participant